(1 - 12 von 18
)
PhoreMost raises £11m to enter world of drug discovery -...
www.cambridge-news.co.uk
This firm has several promising targets
eventflo - Chris Torrance
www.myeventflo.com
Dr Chris Torrance is CEO of PhoreMost Ltd; a company he founded with Ashok Venkitaraman in to systematically de-orphan key disease-driving targets...
A Phenotypic Screening Technology Aimed at Drugging Undruggable ...
www.dfhcc.harvard.edu
Dr. Chris Torrance, CEO and Co-Founder of PhoreMost Ltd. (Cambridge, UK) presents a talk titled, "A Phenotypic Screening Technology Aimed ...
First and PhoreMost alliance in neurodegenerative disease | Business...
www.www.businessweekly.co.uk
Biopharma startup PhoreMost is collaborating with a top Cambridge University laboratory to identify innovative drug targets for neurodegenerative disease....
sortiert nach Relevanz / Datum